SINSIN PHARMACEUTICAL Co., LTD. Logo

SINSIN PHARMACEUTICAL Co., LTD.

002800 | KO

Overview

Corporate Details

ISIN(s):
KR7002800001
LEI:
Country:
South Korea
Address:
세종특별자치시 소정면 소정산단동로 9 -, 세종특별자치시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-03-26 00:00
AGM Information
정기주주총회결과
Korean 26.2 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 24.5 KB
2025-03-18 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 418.8 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 119.4 KB
2025-03-11 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 114.8 KB
2025-02-05 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.2 KB
2025-02-05 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 12.8 KB
2025-01-22 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2025-01-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2025-01-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-12 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 1.1 MB

Automate Your Workflow. Get a real-time feed of all SINSIN PHARMACEUTICAL Co., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SINSIN PHARMACEUTICAL Co., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SINSIN PHARMACEUTICAL Co., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ELUTIA INC. Logo
Develops drug-eluting biologics to reduce complications from medical implants.
United States of America
ELUT
Emergent BioSolutions Inc. Logo
Develops and manufactures medical countermeasures for public health and national security threats.
United States of America
EBS
ENANTA PHARMACEUTICALS INC Logo
Developing novel small molecule drugs for virology (HCV, RSV) and immunological diseases.
United States of America
ENTA
Enervit Logo
Produces sports nutrition & wellness supplements for athletes and active lifestyles.
Italy
ENV
enGene Holdings Inc. Logo
Developing non-viral, locally administered gene therapies for rare genetic conditions.
United States of America
ENGN
Enliven Therapeutics, Inc. Logo
A clinical-stage biopharma developing kinase inhibitors for precision oncology cancer treatment.
United States of America
ELVN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel
ENLV
Enlivex Therapeutics Ltd. Logo
Developing cell therapy that reprograms macrophages to treat immune hyper-responses like sepsis.
United States of America
ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden
ERMA
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610

Talk to a Data Expert

Have a question? We'll get back to you promptly.